Accelerating Progress in Pediatric Cancer
NCI is pushing the “bench to bedside” paradigm to bring medical advances into the clinic.
Pediatric cancers are considered rare diseases, which makes them more challenging to study and treat. However, efforts like the Childhood Cancer Data Initiative are helping to further disease biology understanding and open pathways for community collaboration. In light of Childhood Cancer Awareness Month, NCI experts discuss the future of advancements such as precision medicine and immunotherapy.
-
Dr. Nirali Shah Hematologic Malignancies Section Head, Pediatric Oncology NCI
-
Dr. Christine Heske Translational Sarcoma Biology Group Head, Pediatric Oncology NCI
-
NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
32m listen -
Cyber Resilience and Recovery Amid Evolving Cyber Threats
Data durability is a key aspect of NIST’s cybersecurity framework for public and private organizations.
21m listen -
How Tech Enables Environmental Justice at EPA
The agency wants to eliminate bias and establish new tech standards to reduce greenhouse gas emissions.
39m listen -
Building Better Data Governance Across FDA
The agency is using emerging technology to tackle its data challenges.
19m listen